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The photochemical thiol–ene reaction as a
versatile method for the synthesis of glutathione
S-conjugates targeting the bacterial potassium
eﬄux system Kef†
Jess Healy,*a,b Tim Rasmussen,c Samantha Miller,c Ian R. Boothc and
Stuart J. Conway*a
The thiol–ene coupling reaction is emerging as an important conjugation reaction that is suitable for use
in a biological setting. Here, we explore the utility of this reaction for the synthesis of glutathione-S-con-
jugates (GSX) and present a general, operationally simple, protocol with a wide substrate scope. The GSX
aﬀorded are an important class of compounds and provide invaluable molecular tools to study gluta-
thione-binding proteins. In this study we apply the diverse library of GSX synthesised to further our under-
standing of the structural requirements for binding to the glutathione-binding protein, Kef, a bacterial K+
eﬄux system, found in many bacterial pathogens. This system is vital to the survival of bacteria upon
exposure to electrophiles, and plays an essential role in the maintenance of intracellular pH and K+
homeostasis. Consequently, Kef is an appealing target for the development of novel antibacterial drugs.
Introduction
The rapid and continual rise of bacterial resistance to many
frontline antibiotic treatments necessitates the urgent identifi-
cation of novel antibiotic targets.1 Consequently, the develop-
ment of small molecule ligands that modulate the activity of
such targets will be essential in the validation of their thera-
peutic potential. The bacterial potassium (K+) eﬄux system,
Kef, is a K+/H+ antiporter that plays a vital role in promoting
cell survival by modulating cytoplasmic pH during electro-
philic insult. Kef-like systems are found across the spectrum of
bacteria, including in the ESKAPE pathogens, which are
responsible for the majority of hospital acquired infections.2
The Kef system integrates detoxification of electrophiles via
GSH metabolites with activation of K+ eﬄux. Kef’s protective
eﬀect stems from the associated drop in the cytoplasmic pH
on activation of K+ eﬄux, which is thought to result in proto-
nation of the nucleophilic groups on DNA and proteins – pre-
venting damage caused by exposure to electrophiles.3 Previous
work has shown the magnitude and rate of activation of Kef to
be a vital determinant in cell survival on exposure to toxic electro-
philes. Kef thus presents an appealing target for antibiotic
drug development.4,5 The archetypal E. coli Kef system is a
complex multi-domain membrane protein, which contains a
cytosolic ligand-binding KTN domain. It is inactive in the pres-
ence of GSH, and activated by GSH conjugates (GSX) formed
on exposure of the cell to electrophiles. Evidence garnered
through a combination of classical mutagenesis and crystallo-
graphic studies led to the proposal of a model for regulation of
K+ eﬄux by the negative and positive eﬀectors, GSH and GSX,
respectively.3 The peptide core is tethered at either end by a
number of key basic residues, R416, R516 and N551. Muta-
genesis had previously identified these residues as vital for
GSH/GSX recognition,6 and crystallography confirmed their
importance as key contacts for the peptide backbone (Fig. 1).
Crystallography also suggested a conformational change on
binding of GSX, particularly around residue F441 that caps the
thiol-binding site in what is proposed to be a ‘closed’
conformation. This hypothesis was tested by site directed
mutagenesis, where conservative changes (e.g. F441W) had
little eﬀect on gating but more disruptive changes (e.g. F441L
or F441D) resulted in significantly impaired activation of K+
eﬄux.3 Thus F441 was proposed to be involved in activation of
K+ eﬄux. ‘Chemical mutagenesis’, i.e. investigation of the
eﬀect of varying the nature of the thiol substituent on both
binding and gating, was consistent with the proposed model
for channel activation.7 In our previous study, a number of
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ESG (S-N-ethylsuccinimidyl glutathione) analogues were exam-
ined and it was found that larger substituents on the nitrogen
atom of the succinimidyl ring including tBu (KD = 400 nM),
Bn and Cy had a higher aﬃnity for Kef than the parent com-
pound. Additionally, open chain analogues containing 5, 6 or
8 (KD = 4.4 µM) carbons bound with similar aﬃnity to ESG,
indicating that an increase in hydrophobicity and size corres-
ponded to an increase in aﬃnity for the target. However,
examination of the eﬀect of these GSX on the rate of K+ eﬄux,
revealed a diﬀerentiation between aﬃnity and gating. The
structurally rigid succinimidyl analogues were eﬃcient activa-
tors, whereas the more flexible analogues resulted in a lower
rate of K+ eﬄux, despite similar aﬃnities. These data suggest
that a degree of structural rigidity in the S-substituent is
required for eﬃcient gating of Kef.
The ligands employed in this work were exclusively formed
by conjugate addition of GSH to a range of enones.7 While this
approach was informative in revealing that both steric bulk
and structural rigidity are required for Kef activation, the range
of sulfur substituents that we could employ were necessarily
limited by the requirement for electrophilic reactivity. There-
fore, we sought to employ alternative chemistry to conjugate
the thiol group of GSH to a range of structurally diverse
moieties. Recent advances in the photochemical thiol–ene
coupling (TEC) reaction led us to investigate the use of this
chemistry to produce derivatives of GSH.
The TEC reaction8–10 is emerging as a useful tool in biologi-
cally-important conjugation reactions.11 This transformation,
which occurs between thiols and alkenes, has many attractive
features as it often fulfils the ‘click’ criteria as defined by
Sharpless et al.12 The biocompatibility of the reaction
conditions also provides a viable alternative to the Cu-cata-
lysed Huisgen cycloaddition for the ligation of peptides and
proteins.12–14 Alternatives to the Cu-catalysed Huisgen cyclo-
addition are important as the use of this reaction can be com-
plicated by the presence of the Cu catalyst.15,16 Until recently,
the TEC had been predominantly employed in polymer and
materials chemistry, but recent work has firmly established
this reaction in the field of bioconjugation, where it has found
applications in glycobiology, the synthesis of
thioglycosides,17–21 the detection of thio-phosphorylated pro-
teins,22 protein spin labelling,23 tandem application with
native chemical ligation for the synthesis of S-modified pep-
tides,24 lipidated peptides,25 the development of lipophilic
amino sugar libraries,26 and the synthesis of stapled pep-
tides.27 Waldmann et al. have utilised this methodology in the
synthesis of S-lipidated cysteine derivatives, and more recently
to the immobilisation of proteins in microarrays.28–31 The TEC
has also found wide application in polymer chemistry,32 and
biopolymer applications, for example the synthesis of glycol-
microspheres.33 Despite these successes, Dondoni11 noted that
TEC conditions are not always general and that significant
optimisation can be required for each individual system.
Additionally, considering the importance of glutathione (GSH,
4) in biological processes, there have been limited examples of
the application TEC to this ubiquitous peptide and in each
case GSH modification was not the main focus of these
studies.17–19,34 Here, we explore the utility of the TEC reaction
to generate a diverse library of GSX. This library was sub-
sequently employed to investigate the requirements for high
aﬃnity to the ligand-binding domain of the Kef system from a
model organism, Shewanella denitrificans (SdKefQCTD).7
Results and discussion
Optimisation of thiol–ene coupling conditions
Our interest in the TEC reaction was motivated by our desire to
synthesise a stable S-dansyl-labelled GSH derivative (3,
Scheme 1). This molecule was required as a fluorescent probe
to detect binding of small molecules to Kef.7 Direct reaction of
dansyl chloride with the thiol of GSH results in the formation
of a scissile S–S bond, which rearranges to the more stable
N-acyl compound. Based on our structure–activity relationship
(SAR) studies, we wished to produce a GSX derivative with the
fluorophore attached to the thiol. Therefore, we adopted a
Fig. 1 The GSH (carbon = yellow) binding site of E. coli KefC, highlight-
ing key residues. This ﬁgure was generated with PyMOL using the GSH
bound E. coli KefC structure (PDB: 3L9W).
Scheme 1 Synthesis of S-dansylglutathione (DNGSH) 3. Reagents and
conditions: a. allylamine, DIPEA, CH2Cl2, 100% b. GSH, DPAP, TCEP·HCl,
hν, THF/H2O, 40%.
7
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strategy reported by Waldmann et al.31 and synthesised N-allyl-
5-(dimethylamino)naphthalene sulfonamide (2) from dansyl
chloride (1). Installation of an allyl group provided a synthetic
handle for linkage of the fluorophore to GSH via the TEC,
forming a stable thioether bond. Using conditions similar to
those reported by Fiore et al.35 and Staderini et al.,36 a house-
hold UV lamp (4 × 15 W, 365 nm) was used as the light source
and 2,2-dimethoxyphenyl acetophenone (DPAP) as the
initiator. Due to the disparate solubilites of the reagents, a
mixture of THF and water (1 : 2) were used as solvents, allowing
for partial solubilisation of the alkene substrate. Initial
attempts provided the desired compound in yields of 8–14%
(Table 1, entries 1–3). The primary product, however, was the
disulfide (GSSG). Addition of a reducing agent tris(2-carboxy-
ethyl)phosphine (TCEP·HCl) resulted in a significant
improvement in yield to 40% (Table 1, entry 4). Thorough
degassing of solvents was found to have no eﬀect on the
observed yield (Table 1, entries 5 and 6).
Compound 2 is a challenging substrate for the TEC. The
thiyl radical reacts more readily with electron-rich enes due to
its electrophilic nature, thus the initial rate of addition is
expected to be slow for this compound.14,32,37 Additionally,
compound 2 contains a heteroatom in the allylic position
making it sensitive to elimination to the allyl sulfide after the
addition step (Fig. 2).37,38 Given our encouraging results with
this challenging ene we were keen to further investigate the
scope of this reaction for the generation of structurally distinct
GSX as probe compounds for Kef.
We optimised the reaction conditions using the simple
terminal alkene, decene, as a model system (Scheme 2, 5c).
Using the conditions that we had previously developed a mode-
rate yield of 45% was obtained (Table 2, entry 1). To simplify
the purification of the product we excluded the reducing
agent, which had no significant eﬀect on the yield of S-labeled
peptide obtained with this simple substrate. This result
indicates that the GSSG during the formation of 3 resulted
from the slower reaction rate of 2 in the TEC. Shortening the
irradiation time was found to decrease the yield (Table 2, entry
2, 15%), while an increase in the irradiation time gave no
improvement (Table 2, entry 6). We found, however, that the
amount of initiator could be reduced to 20 mol% without any
impact on the isolated yield (Table 2, entry 5), when using
decene. With standard conditions established using a simple
substrate, a series of alkenes were selected to probe the scope
of the reaction, and which would provide a diverse SAR profile
for Kef.
With simple, terminal and unfunctionalised alkenes the
yields ranged from 45% to 97% (Scheme 2, 5a, c, d, e, g). Iso-
lation in all cases was by filtration followed by crystallisation
from boiling ethanol and water. With hexene as the ene
substrate the resulting labeled peptide was obtained in very
Fig. 2 The thiol–ene coupling reaction.
Scheme 2 Scope of thiol–ene coupling to alkyl and heteroalkyl sub-
strates. Reagents and conditions: a. alkene (1 eq.), DPAP, THF/H2O, hν.
% yields quoted are isolated yields.
Table 2 Reaction optimisation for simple alkene system (5c)a
Entry DPAP t (h) Yieldb (%)
1 0.5 5 45
2 0.5 1 15
3 0.2 2 5
4 0.2 3 18
5 0.2 5 45
6 0.2 8 31
a Ratio of GSH : decene (4 : 1), and solvent system THF/H2O (1 : 2) in all
cases. b Yields represent isolated yields following purification by
crystallisation from EtOH/H2O.
Table 1 Optimisation of reaction conditions for the synthesis of 3aa
Entry GSH : dansyl t (h) Yieldb (%)
1 2 : 1 17 14
2 2 : 1 34 8
3 4 : 1 5 13
4c 4 : 1 5 40
5c 4 : 1 5 32
6 4 : 1 5 18
a 0.5 eq. DPAP used in all cases. Entry 5: degassed THF/H2O, entry 6:
degassed DMF/H2O.
b Yields quoted are isolated yields following
purification by RP C-18 silica gel column chromatography. cDenotes
addition of TCEP·HCl.
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high yields (97%, 5a). By comparison, reaction with cyclo-
hexene resulted in a significantly lower yield (59%, 5b), as
expected due to increased reversibility of the initial thiyl
radical addition to the internal alkene (Fig. 2).37
(−)-β-Pinene (5l) and (+)-α-pinene (5k) were both very poor
TEC substrates, with less than 1% of the desired adduct iso-
lated in both cases. These low yields could result from a
number of factors: (1) slow rate of hydrogen radical abstraction
by the stable carbon radical, formed by both 5k and 5l could
mask the expected diﬀerences in the rate of reaction with the
internal vs. external alkene; or (2) rearrangement or fragmenta-
tion of the radical intermediate might result in unwanted pro-
ducts. Reaction with heteroatom-containing allylic substrates
(5f, h, i) proceeded well in all cases. However, due to the
increased solubility of the hydroxyl- and amino-containing
adducts (5h and 5i), purification by reverse phase C-18 silica
gel column chromatography was required. These compounds
are interesting, however, as they provide handles for further
synthetic elaboration. The heterocyclic pyrrolidinone (5j) was
also well tolerated.
A series of aryl-substituted, vinyl and allyl alkenes were next
investigated (Scheme 3). Styrene (Scheme 3, 6f ) is a poor TEC
substrate,14 and in our hands yielded the desired adduct in
moderate yield (53%). Considering the reaction mechanism
(Fig. 2), modification of the electronic properties of the aryl
ring by substitution was predicted to aﬀect the overall reaction
yield, and this was indeed found to be the case. Addition of
electron-withdrawing groups in the para-(6a and 6c) or ortho-
(6b) positions of the ring resulted in a decreased yield of the
adduct. The electron poor vinyl sulfone (6e) also resulted in a
low yield of the labelled peptide. The reduced yields in these
cases can be rationalised by either the low reactivity of the
electrophilic thiyl radical with these electron-poor alkenes, or a
slower hydrogen radical abstraction step. For the para-nitro
analogue, competing reduction to the aniline was also
observed, and consequently the purity of 6a was lower that of
the other GSX in this series. Addition of a methylene unit to
the 4-fluoro derivative improved the observed yield (6d, 90% cf.
6c, 39%), due to the loss of conjugation with the aromatic
system. Conversely, addition of a para-methoxy substituent
resulted in an increase in yield of the desired adduct (6g,
84%), due to the increased electron density of the alkene in
this case. It can be seen from the data presented here that elec-
tron-rich alkenes are better substrates for this reaction due to
their greater reactivity with the electrophilic thiyl radical. This
observation is consistent with the reactivities trends observed
in polymer chemistry.14
Electron-poor alkenes provide lower yields in this reaction
as they react less readily with the electrophilic thiyl radical.
Additionally, we found that for particularly challenging sub-
strates the yield may be increased by modification of the elec-
tronic properties of the ene via appropriate substitution, or by
the addition of TCEP·HCl as a reducing agent (Table 1, entry 4
and Scheme 3, 6c). This second observation is contrary to a
report by Scanlan et al., in which an increase in competing
radical desulfurisation was observed in the presence of tBu3P
as reducing agent, this was not observed in our hands with
TCEP as the phosphine reducing agent.24
Investigation of the eﬀect of the nature of the S-substituent on
Kef binding
The structurally diverse GSX that we synthesised were evalu-
ated for their ability to bind Kef from S. denitrificans. A soluble
construct of Kef from S. denitrificans (SdKefQCTD), containing
the ligand-binding KTN domain, the Q-linker (which links the
cytosolic and membrane domains) and a 10-residue regulatory
loop from the membrane domain (GHELEVDIEP), was
employed for all biophysical analyses and was purified as pre-
viously described.7 Kef from S. denitrificans was used as a
model system as it lacks the ancillary cytoplasmic protein
subunit KefF, which is required for full activation in E. coli,
and could complicate biophysical analysis of ligand binding.
Two complementary methods were employed to examine
ligand binding to SdKefQCTD: diﬀerential scanning fluori-
metry (DSF)39 and a fluorescence competition assay using
DNGSH (3). DSF relies on an increase in fluorescence that
results from SYPRO orange binding to hydrophobic regions of a
soluble protein that are exposed by thermally-induced protein
unfolding, giving a melting temperature for the protein (Tm).
Repeating the process in the presence of a ligand (that binds to
a folded state of the protein) usually results in an increase in Tm.
The change in Tm between the free and ligand-bound protein
(ΔTm) correlates with ligand’s aﬃnity for the protein.40–42
In depth biophysical evaluation of compound 3, which is
employed in the fluorescence competition assay, has been
described previously.7 Briefly, the dansyl chromophore is a
solvatochromic probe, which is sensitive to the nature of its
environment. On binding to SdKefQCTD, i.e. a transition from
a hydrophilic to a hydrophobic environment, both an increase
in the quantum yield of fluorescence of 3 and a hypsochromic
shift in the λmax of emission are observed. Displacement of the
probe by a competing ligand results in a drop in fluorescence
intensity that can be used to identify new ligands for
SdKefQCTD. Quantitative data can be obtained by titration of
SdKefQCTD and 3 with increasing concentrations of the com-
peting ligand, and fitting of the resulting binding isotherm.
Good correlation of the data obtained using both methods was
observed, as previously reported. Additionally FB/FL values
Scheme 3 Scope of thiol–ene coupling to aryl substrates. Reagents
and conditions: a. alkene (1 eq.), DPAP, THF/H2O, hν. % yields quoted are
isolated yields. * denotes the use of TCEP·HCl.
Research Article Organic Chemistry Frontiers
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(where FB = fluorescence intensity 3 + SdKefQCTD and FL =
fluorescence intensity 3 + SdKefQCTD + GSX and an FB/FL > 1
indicates binding), have shown good correlation with the
aﬃnities obtained using quantitative methods.7
Evaluation of the aliphatic and heteroatom containing GSX
(Scheme 2, 5a–5j) demonstrated that compounds with simple
aliphatic substituents bound with a similar aﬃnity to the
known activator ESG (KD = 12 µM) (Fig. 3A and B).
7 The
smaller, more polar, analogues 5h and 5i were found to bind
to SdKefQCTD with a lower aﬃnity, similar to that observed
for the native ligand GSH (KD = 900 µM) (Fig. 3A and B), and a
known weak activator of E. coli KefC, S-lactoyl glutathione
(SLG, KD = 900 µM). A small recovery in binding eﬃciency was
observed for the larger pyrrolidinone analogue 5j.
For the aromatic analogues (Scheme 3, 6a–6g), SdKefQCTD
binding of a similar magnitude to the positive control ESG was
observed in all cases (Fig. 3C and D). The analogue containing
the para-nitro (6a) substituent and the unsubstituted derivative
6f were the only cases for which a statistically significant
increase in binding aﬃnity relative to ESG was observed in the
fluorescence assay (p ≤ 0.05 in both cases). Also of note, a
reduction in SdKefQCTD aﬃnity was observed for the 4-F
derivative (6c), which could be recovered through the introduc-
tion of an additional methylene unit between the sulfur atom
and the aromatic ring (6d).
Conclusions
In conclusion, we have shown that the TEC is a simple, versa-
tile and reliable method for the synthesis of novel GSH deriva-
tives. The conditions that we have developed are operationally
simple and high yielding. It is noteworthy that in all cases, no
eﬀort was made to exclude oxygen. For most substrates the
product could be isolated by simple filtration and purified by
crystallisation from ethanol and water. Most significantly, for
more challenging substrates the yield can be improved
through the addition of a reducing agent (TCEP·HCl).
The diverse library of GSX synthesised using this methodo-
logy contained analogues with simple aliphatic (cyclic and
acyclic) substituents, small polar heteroatom containing func-
tional groups and a series of substituted styrenes. This set of
probe compounds was tested for their ability to bind to
SdKefQCTD, and it was found that those ligands containing
bulky, hydrophobic substituents bound with greater aﬃnity
than those with small polar groups. These data enhance our
understanding of Kef SAR, and is invaluable for our continued
understanding of the Kef system and attempts to determine
whether this protein is a therapeutically useful target for anti-
bacterial drugs. The compounds will also potentially find use
in the investigation of other GSH-binding proteins.
Experimental section
Strains and plasmids
The strains and plasmids used in this study were described
previously.7 Briefly, the strain used for protein expression and
purification was MJF373 (derived from MJF276 ΔkefFC:kan,
Δcrp kefB:Tn10). A soluble construct, pTrcSdKefQCTD, of Kef
from S. denitrificans was used for protein expression. The con-
struct was derived from pTrcSdKefH6 of the Kef gene from
S. denitrificans OS217 (accession number NC007954.1) starting
at K391 with a further 10 amino acid sequence (GHELEVDIEP)
fused at the 5′ end (corresponds to a suspected regulatory
loop).
Protein expression and purification
pTrcSdKefQCTD was transformed into the E. coli strain
MJF373 for expression. The cell culture was grown in LB media
(0.5 L, containing 0.1% glucose) at 37 °C until an OD650 of 0.8
was reached. After this time the culture was cooled to 30 °C,
followed by induction with IPTG (0.8 mM). The cells were incu-
bated at this temperature for a further 3 h, harvested and
stored at −80 °C until required. Cell lysis was achieved using a
French Press (SLM Aminco) at a pressure of 18 k psi. The
lysate was centrifuged (4700 rpm, 30 min, 4 °C) and the super-
natant collected and filtered (Sartorius Minisart single use
filter, 0.45 µm pore size). The lysate was loaded into a glass
column containing His-Select Nickel aﬃnity gel (under gravity
at 4 °C), washed with wash buﬀer (40 mL containing: 50 mM
Na–phosphate buﬀer pH 7.5, 150 mM NaCl, 10% glycerol,
20 mM imidazole). Bound protein was subsequently eluted
(50 mM Na–phosphate buﬀer pH 7.5, 150 mM NaCl, 10% gly-
cerol, 300 mM imidazole). Buﬀer exchange was achieved using
PD-10 columns (GE Healthcare). The purity of resulting
protein was verified by SDS-PAGE gel electrophoresis. Protein
Fig. 3 Fluorescence competition (A and C) and DSF (B and D) data for
GSX. Error bars represent the standard deviation (n = 3). Signiﬁcance of
changes evaluated by Student’s t-test relative to GSH (where ****p ≤
0.0001, ***p ≤ 0.001, **p ≤ 0.01. *p ≤ 0.05). FB/FL = FI(Kef + 3)/FI(Kef +
3 + GS-X) and ΔTM is the diﬀerence in TM in the presence of ligand rela-
tive to that of the protein alone.
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concentration was determined by UV/VIS spectrophotometry
(ε = 17 420 M−1 cm−1).
Diﬀerential scanning fluorimetry
Assays were performed using a Stratagene Mx3005P qPCR
(Sybr filter, ex. 492 nm, em. 516 nm). The initial temperature
was set to 25 °C, increasing in increments of 1 °C. The Tm
(melting temperature) was identified by fitting to the Boltz-
mann equation (Prism 5).39 The change in unfolding tempera-
ture (ΔTm) was calculated as the shift in Tm relative to the Tm
of the protein in the absence of any ligand. A student T-test
was performed to ensure that the changes were statistically sig-
nificant. Solutions of the ligands under examination were pre-
pared in DMSO or dH2O at a final concentration of 100 mM.
These stock solutions were subsequently diluted to a concen-
tration of 10 mM in buﬀer containing 50 mM Na–phosphate,
150 mM NaCl, pH 7.5. A protein master mix was prepared con-
taining SdKefQCTD (40 µM) and Sypro Orange (1 : 1000
dilution, Invitrogen). Ninety-six well plates (Axygen) were pre-
pared using the protein master mix (22.5 µL, 12 µM) and the
appropriate ligand (2.5 µL). Controls were performed with dye
alone, ligand and dye, and the protein alone.
Fluorescence measurements
For qualitative competition fluorescence measurements a
Perkin Elmer Luminescence Spectrometer was used. Samples
were excited at 340 nm and the emission spectra measured
between 400 & 600 nm. Samples were prepared containing
6 μM SdKefQCTD and 5 μM DNGSH. A decrease in fluo-
rescence intensity after the addition of the desired competing
ligand, at a final concentration of 1 mM, was interpreted as an
indication of binding. The data are reported as the ratio of the
fluorescence intensity before and after the addition of the
ligand under examination at 525 nm (FB/FL). A student’s T-test
was performed to determine whether the changes were statisti-
cally significant.
Synthetic chemistry general information
All reagents were purchased from Sigma Aldrich or Alfa Aesar
and were used without further purification. The UV light
source was provided by a Philips HB175 Facial Solarium (UVA,
365 nm, P = 4 × 15 W). Reverse phase column chromatography
was carried out on Fluka Ltd silica gel 100 C18-reversed phase,
under a positive pressure of compressed air. Analytical TLC
analysis was performed using Merck 60 RP-18 F254S
aluminium-supported thin layer chromatography sheets and
visualised using ninhydrin. 1H and 13C NMR spectra were
recorded on a Bruker Avance 400 (400 MHz, 100 MHz, respecti-
vely) or Bruker Avance III (500 MHz, 125 MHz, respectively). 1H
and 13C spectra were assigned using 2D NMR experiments
including COSY, HSQC and HMBC. Melting points were per-
formed on a Kofler Hotstage microscope and are uncorrected;
the crystallisation solvent is shown in parentheses. IR spectra
were recorded using a Bruker Tensor 27 spectrometer. Elemental
analyses were submitted to the Elemental Analysis Service,
London Metropolitan University. Optical rotations were recorded
at 20 °C at the sodium D line (589 nm). ESG was prepared as pre-
viously reported.3 Selected examples of synthetic procedures are
included below. Further details are available in the ESI.†
N-Allyl-5-(dimethylamino)naphthalene-1-sulfonamide (2).
To allylamine (21 mg, 28 μL, 0.37 mmol, 1 eq.), and diiso-
propylethylamine (239 mg, 1.85 mmol, 5 eq.) in CH2Cl2 (5 mL)
a solution of dansyl chloride (100 mg, 0.37 mmol, 1 eq.) in
CH2Cl2 (3 mL) was added. The reaction was stirred at RT over-
night. After 18 h the reaction was adjudged to be complete by
TLC analysis, concentrated in vacuo and purified by silica gel
column chromatography eluting with ethyl acetate and
petroleum ether (20 : 80), furnishing N-allyl-5-(dimethylamino)
naphthalene-1-sulfonamide (109 mg, 100%) as a fluorescent
yellow crystalline solid: Rf 0.15 (ethyl acetate/petroleum ether
20 : 80); m.p. 62–66 °C (CH2Cl2); νmax (thin film)/cm
−1; 1644,
(s), 1316 (m); 1H NMR (400 MHz, CDCl3): δ 8.56 (d, J = 8.6 Hz,
1H,), 8.30 (d, J = 8.6 Hz, 1H), 8.26 (d, J = 8.6 Hz, 1H), 7.58 (dd,
J = 7.8, 1.1 Hz, 1H), 7.53 (dd, J = 7.8, 1.1 Hz, 1H), 7.2 (d, J = 7.6
Hz, 1H), 5.69–5.57 (m, 1H), 5.09 (ddt, J = 17.0, 1.2 Hz, 1H), 5.01
(ddt, J = 10.2, 1.2 Hz, 1H), 4.75 (t, J = 6.2 Hz, 1H), 3.54 (ddd, J =
12.2, 6.2, 1.2 Hz, 2H), 2.90 (s, 6H); 13C NMR (100 MHz, CDCl3):
δ 151.9, 134.7, 133.0, 130.5, 129.8, 129.6, 129.6, 128.4, 123.2,
118.8, 117.5, 115.3, 45.8, 45.4; HRMS m/z (ES+) [Found; (M +
Na)+ 313.0891 C15H18N2NaO2S requires M
+, 313.0987]; m/z
289.10 ([M − H]−, 100%); Anal. Calcd for C15H18N2O2S: C, 62.0;
H, 6.2; N, 9.6. Found: C, 62.0; H, 6.3; N, 9.6.7
S-((5-(Dimethylamino)naphthalen-1-yl)sulfonylaminopropyl)
glutathione (3). N-Allyl-5-(dimethylamino)naphthalene-1-sulfo-
namide (100 mg, 0.34 mmol, 1 eq.), L-glutathione (420 mg,
1.36 mmol, 4 eq.), TCEP·HCl (194 mg, 0.68 mmol, 2 eq.) and
2,2-dimethoxyphenyl acetophenone (17 mg, 0.07 mmol, 0.2
eq.) were stirred at RT in THF/H2O (1 : 2, 3 mL) in the presence
of light (365 nm, 4 × 15 W) for 5 h. After which time the reac-
tion was extracted with CH2Cl2 (2 × 5 mL). The aqueous layer
was lyophilised and the crude material purified by RP C-18
silica gel column chromatography (MeOH/H2O 0 : 100, 50 : 50),
furnishing S-((5-(dimethylamino)naphthalen-1-yl)sulfonyl-
aminopropyl) glutathione 3 (88 mg, 40%) as a hygroscopic
yellow solid: Rf 0.35 (MeOH : H2O 50 : 50); [α]
25
D −19.2 (c 0.25,
H2O); νmax (PTFE card)/cm
−1; 3057 (w), 1719 (m), 1647 (m),
1527 (m), 1153 (m); 1H NMR (500 MHz, D2O): δ 8.35 (d, J = 8.5
Hz, 1H), 8.15 (d, J = 8.5 Hz, 1H), 8.11 (d, J = 7.5 Hz, 1H),
7.88–7.55 (m, 2H), 7.26 (d, J = 7.5 Hz, 1H), 4.20 (dd, J = 8.5,
5.1 Hz, 1H), 3.67–3.52 (m, 3H), 2.85 (t, J = 6.8 Hz, 2H), 2.73 (s,
6H), 2.43 (dd, J = 13.9, 5.1 Hz, 1H), 2.39–2.28 (m, 3H), 2.07 (t, J =
6.8 Hz, 2H), 2.04–1.96 (m, 2H), 1.34 (qn, J = 6.8 Hz, 2H); 13C NMR
(125 MHz; D2O): δ 176.0, 174.7, 173.9, 171.6, 151.3, 133.9, 130.1,
129.9, 128.9, 128.8, 128.7, 128.3, 123.9, 119.0, 115.9, 54.1, 52.8,
44.8, 43.2, 40.7, 32.5, 31.4, 28.2, 27.6, 26.2; HRMS m/z (ES−)
[Found; (M − H)− 596.1852 C25H34N5O8S2 requires M−, 596.1854];
m/z (ES−) 596.2 ([M − H]−, 100%); Anal. Calcd for C25H35N5O8S2:
C, 50.2; H, 5.9; N, 11.7. Found 50.1; H, 5.7; N, 11.7.7
General procedure for the synthesis of GSX
The desired alkene (0.34 mmol, 1 eq.), L-glutathione (420 mg,
1.36 mmol, 4 eq.) and 2,2-dimethoxyphenyl acetophenone
Research Article Organic Chemistry Frontiers
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(17 mg, 0.07 mmol, 0.2 eq.) were stirred at RT in THF/H2O
(1 : 2, 3 mL) in the presence of light (365 nm, 4 × 15 W) for 5 h.
After this time the reaction mixture was filtered, and the solid
washed with ethanol and water. The crude solid was further
purified by crystallisation from boiling H2O and ethanol (×2)
unless otherwise stated. [Note: where no precipitate formed,
the reaction was washed with dichloromethane (×2) and the
aqueous layer lyophilized. In this case, the crude material was
purified by RP C-18 silica gel column chromatography]. Data
shown for selected examples see ESI† for further details.
S-Propyl-3-trimethylsilylglutathione (5f ) was isolated as a
colourless solid (120 mg, 85%): Rf 0.16 (MeOH/H2O 50 : 50);
[α]20D −29.0 (c 0.5, 2 M NaOH); m.p. 228 °C (dec.) (EtOH/H2O);
νmax (thin film)/cm
−1; 3372 (m), 3345 (m), 2954 (m), 1672 (s),
1645 (s), 1513 (s) 1432 (m); 1H NMR (400 MHz, D2O/NaOD, pH
12): δ 4.83 (dd, J = 9.2, 4.9 Hz, 1H), 3.65 (d, JAB = 17.3 Hz, 1H),
3.58 (d, JBA = 17.3 Hz, 1H), 3.11 (dd, J = 7.2, 6.0 Hz, 1H), 2.93
(dd, J = 14.2, 4.9 Hz, 1H), 2.69 (dd, J = 14.2, 9.2 Hz, 1H),
2.50–2.39 (m, 2H), 2.30–2.15 (m, 2H), 1.87–1.63 (m, 2H),
1.50–1.38 (m, 2H), 0.44 (t, J = 8.1 Hz, 2H), −0.16 (s, 9H); 13C
NMR (125 MHz, D2O/NaOD, pH 12): δ 182.8, 176.6, 176.5,
172.4, 55.9, 53.6, 43.8, 35.7, 32.6, 31.3, 31.2, 24.2, 15.8, −1.8;
HRMS m/z (ES−) [Found; (M − H)− 420.1638. C16H30N3O6SSi
requires M−, 420.1360.]; m/z (ES−) 420.1 ([M − H]−, 100%);
Anal. Calcd for C16H31N3O6SSi: C, 45.6; H, 7.4; N, 9.9. Found
C, 45.6; H, 7.4; N, 10.1.
2-(2-Oxopyrolid-1-yl)-S-ethyl glutathione (5j) was isolated as
a hygroscopic colourless solid (118 mg, 83%): Rf 0.6 (H2O);
[α]20D −27.4 (c 0.5, H2O); νmax (thin film)/cm−1; 3340 (w), 2360
(s), 1740 (s), 1652 (m), 1558 (m); 1540 (m), 1291 (w); 1H NMR
(400 MHz, D2O): δ 4.44 (dd, J = 8.6, 5.1 Hz, 1H), 3.84 (s, 2H),
3.69 (dd, J = 6.4, 6.4 Hz, 1H), 3.42–3.33 (m, 4H), 2.94 (dd, J =
14.2, 5.1 Hz, 1H), 2.76 (dd, J = 14.2, 8.6 Hz, 1H), 2.67 (t, J = 6.5
Hz, 2H), 2.47–2.36 (m, 2H), 2.31 (t, J = 7.5 Hz, 2H), 2.09–1.99
(m, 2H), 1.91 (qn, J = 7.5 Hz, 2H); 13C NMR (100 MHz, D2O):
δ 178.9, 175.0, 173.8, 173.7, 172.9, 54.0, 53.4, 48.2, 41.9, 41.8,
32.9, 31.5, 31.3, 29.2, 26.3, 17.6; HRMS m/z (ES−) [Found; (M −
H)− 417.1440. C16H25N4O7SNa requires M
−, 417.1444.]; m/z
(ES−) 417.1 ([M − H]−, 100%); Anal. Calcd for C16H26N4O7S: C,
45.9; H, 6.3; N, 13.4. Found: C, 45.8; H, 6.1; N, 13.3.
2-(2-Trifluoromethylphenyl)-S-ethyl glutathione (6b) was
isolated as a colourless solid (64 mg, 39%): Rf 0.4 (H2O/MeOH
50 : 50); [α]20D −16.6 (c 0.5, 2 M NaOH); νmax (thin film)/cm−1;
3434 (w), 1746 (m), 1674 (m), 1645 (m), 1514 (s), 1314 (s), 1233
(m), 1114 (m); 1H NMR (400 MHz, D2O/NaOD, pH 12): δ 7.60
(d, J = 7.8 Hz, 1H), 7.47 (t, J = 7.8 Hz, 1H), 7.37 (d, J = 7.8 Hz,
1H), 7.30 (t, J = 7.8 Hz, 1H), 4.44 (dd, J = 8.9, 4.7 Hz, 1H),
3.66 (d, JAB = 17.2 Hz, 1H), 3.58 (d, JBA = 17.2 Hz, 1H), 3.10 (dd,
J = 7.1, 5.9 Hz, 1H), 3.06–2.94 (m, 3H), 2.83–2.68 (m, 3H),
2.28–2.18 (m, 2H), 1.82–1.62 (m, 2H); 19F NMR (125 MHz, D2O/
NaOD, pH 12); δ −58.9; 13C NMR (125 MHz, D2O/NaOD, pH
12): δ 182.4, 176.3, 176.3, 171.9, 138.4, 132.2, 131.4, 127.8 (d,
J = 29.3 Hz), 126.8, 126.8 (q, J = 5.7 Hz), 124.6 (d, J = 270 Hz),
55.5, 52.9, 43.3, 32.9, 32.4, 32.2, 31.9, 30.8; HRMS m/z
(ES−) [Found; (M − H)− 478.1273. C19H23F3N3O6S
requires M−, 478.1265.]; m/z (ES−) 478.1 ([M − H]−, 100%);
Anal. Calcd for C19H24F3N3O6S: C, 47.5; H, 5.0; N, 8.8. Found:
C, 47.7; H, 4.9; N, 9.1.
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